Infectious Diseases 1007 - Infectious Disease Alert - Jul 01, 2006

Target Audience:

This activity is intended for the infectious disease physician.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Associate Editors
Robert Muder, MD
Hospital Epidemiologist
Pittsburgh VA Medical Center
Section Editor
Hospital Epidemiology

Jessica Song, MA, PharmD
Assistant Professor
Pharmacy Practice
University of the Pacific
Stockton, CA
Pharmacy Clerkship and Coordinator
Santa Clara Valley Medical Center Section Editor
Managed Care

Dean L. Winslow, MD
Chief
Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine Section Editor, HIV

Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor
Updates
Section Editor
HIV

Authors
Jean Yong Nam, PharmD Candidate

Rehan Noori, PharmD Candidate

Subjects:

  • Emergence of MRSA USA300 Clone
  • CA-MRSA & CAP
  • Classifying MRSA—A Modest Proposal
  • An Emerging Extended-Spectrum Triazole Antifungal: Noxafil® (Posaconazole)
  • Discontinuing Non-Nucleoside Reverse Transcriptase Inhibitors
  • Treatment of Rheumatoid Arthritis and Risk of Serious Infection
  • Updates

Objectives:

  • To discuss diagnosis and treatment of infectious diseases
  • To present current data regarding use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • To present the latest information regarding the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • To discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapy

Financial Disclosure:

Infectious Disease Alert’s Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker’s bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck.

Peer Reviewer, Connie Price, MD, reports no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company related to this field of study.

Associate Editor, Robert Muder, MD, Hospital Epidemiologist, Pittsburgh VA Medical Center Dr. Muder does research for Aventis and Pharmacia.

Associate Editor, Jessica Song, MA, Pharmacy Residency Coordinator, Santa Clara Valley Medical Center, report no financial relationship relevant to this field of study.

Associate Editor, Dean L. Winslow, MD, FACP, is a consultant for Bayer Diagnostics and Pfizer/Agouron, and is on the speaker’s bureau for Pfizer/Agouron.

Associate Editor, Carol Kemper, MD, FACP, reports no financial relationship relevant to this field of study.

PharmD Candidate Jean Yong Nam, is at the University of the Pacific School of Pharmacy, and report no financial relationship relevant to this field of study.

PharmD Candidate Rehan Noori, is at the University of the Pacific School of Pharmacy, and report no financial relationship relevant to this field of study.

Copyright 2006 AHC Media. All rights reserved.